Medtronic to join intravascular radiation race with XRT purchase
This article was originally published in Clinica
Medtronic is poised to enter the emerging market of intravascular radiation for restenosis treatment with the acquisition of private company XRT for an undisclosed sum. All XRT executives will remain with the company, which will become part of Medtronic's vascular unit.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.